Tag Archives: HEA

Icertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19

Contract Management Leader Donates INR 15 Lakhs to Renowned Biomedical Research Institute to Test Anti-Tuberculosis (BCG) Vaccine as COVID-19 Treatment

PUNE, India, May 19, 2020 /PRNewswire/ — Icertis, the leading provider of enterprise contract management in the cloud, today announced a contribution of INR 15 Lakhs to Haffkine Institute to support their efforts in testing an anti-tuberculosis vaccine as a treatment for COVID-19. This donation will cover insurance costs to patients, indemnity to nurses, doctors and investigators, drug supplies, and consumables for patient sample testing in the clinical trials of the Bacillus Calmette-Guérin (BCG) vaccine as a means to neutralize the effects of COVID-19.

Icertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19
Icertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19

At this time, when there are no vaccines to stop the pandemic spread nor established curative treatment methods, the need to develop effective treatments has become critical. Heeding to the efforts of the Indian government to curtail further growth of the pandemic, Haffkine Institute is working on the development of new treatment modalities for COVID-19. The Institute is working with the state government, various government-run hospitals and Pune’s BJ Medical College to test potential cures for COVID-19. The trial that Icertis is funding will assess whether BCG can help bolster the immune system of patients.

“The Haffkine Institute has been a center for scientific and industrial research since its inception in 1896,” said Dr. Sanjay Mukherjee, Secretary, Medical Education & Drugs Department, Government of Maharashtra. “We are grateful to Icertis for the generous contribution towards the Institute’s efforts to tackle the spread of COVID-19. We are constantly working on ways to develop new treatments for COVID-19 and this contribution will help our teams immensely as we unite to win this battle against the virus.”

The Haffkine Institute is an autonomous research institute with an illustrious history. Established in 1896 and named after the inventor of the plague vaccine, Dr. Waldemar Mordecai Haffkine, it has operated as a public trust supported by the State of Maharashtra since 1975, focused on training, research and testing to prevent and cure communicable diseases. Much of its research has been focused on testing, monitoring, prevention and treatment of communicable diseases like Influenza, H1N1 and Rabies.

“As the world comes to terms with the enormity of the COVID-19 pandemic, we need to come together to find a cure,” said Monish Darda, CTO & Co-founder Icertis. “Helping to take care of our community is part of the Four Rings of Responsibility that every Icertian wears proudly. And with the Haffkine Institute, there is a personal connection to me and Pune as well – I remember the stories my grandfather used to tell me about life during the plague that hit Mumbai and Pune, and the development of the plague vaccine. We are thankful to Haffkine Institute for working tirelessly to develop a COVID-19 vaccine and are proud to play a small part in the global fight to beat COVID-19.”

Icertis’ gift was made possible by voluntary reductions in pay to CEO and Co-founder Samir Bodas, CTO and Co-founder Monish Darda and continues Icertis’ efforts to address the needs of the community. Last month, Icertis donated INR 25 lakh to ensure the safety of brave doctors, nurses, and hospital staff of Naidu Hospital, Pune, with personal protection equipment, including N95 masks, gowns, and gloves, hand sanitizer dispensers, and viral transport media (VTM) kits, which protect test samples in transit to the lab. Since the start of this pandemic, Icertis has contributed more than US$200,000 to the organizations worldwide, including the University of Washington, the German Red Cross and the Seattle Alliance for Education in its effort to contribute to the communities in which it operates.

For more information about Icertis’ response to the COVID-19 pandemic, visit www.icertis.com/covid-19-resources/.

About Icertis

Icertis, the leading enterprise contract management platform in the cloud, solves the hardest contract management problems on the easiest to use platform. With Icertis, companies accelerate their business by increasing contract velocity, protect against risk by ensuring regulatory and policy compliance, and optimize their commercial relationships by maximizing revenue and reducing costs. The AI-infused Icertis Contract Management (ICM) platform is used by companies like Airbus, Cognizant, Daimler, Microsoft and Sanofi to manage 6.5 million contracts in 40+ languages across 90+ countries. Today, the analyst-validated industry leader serves 5 of the top 10 most valuable companies, 5 of the top 8 pharmaceutical companies, 4 of the top 7 software companies, 3 of the top 5 manufacturing companies and 4 of the top 8 consulting services companies.

Icertis Media Contact:
Haley Flanagan
Manager of Corporate Communications, Icertis
CorpComm@icertis.com  

Genesis BCW Contact:
shruti.singh@genesis-bcw.com;
+91-96544497747

anuj.bhinde@genesis-bcw.com;
+91-7208421492

Logo: https://techent.tv/wp-content/uploads/2020/05/icertis-contributes-to-haffkine-institute-in-support-of-the-fight-against-covid-19-1.jpg  
Photo: https://techent.tv/wp-content/uploads/2020/05/icertis-contributes-to-haffkine-institute-in-support-of-the-fight-against-covid-19.jpg  

FlowForma & MicrotechDPS Join Forces, To Support APAC Region With Process Automation Tools

DUBLIN, May 19, 2020 /PRNewswire/ — FlowForma®, the leading provider of Process Automation tools for Microsoft Office® 365, today announced an exciting new partnership with MicrotechDPS, to deliver the award-winning FlowForma Process Automation tool to organizations in Australia and the greater APAC region.

Olivia Bushe, Chief Executive Officer, FlowForma.
Olivia Bushe, Chief Executive Officer, FlowForma.

A Microsoft partner, MicrotechDPS provide its clients with an extensive range of IT solutions and services to assist and enhance in the day-to-day running of their business. Looking to add a process automation solution to their list of offerings, MicrotechDPS came across the FlowForma Process Automation tool, and quickly sought a demonstration to discover its capabilities.

Upon seeing the tool in action, MicrotechDPS were confident they had found the right process automation app to supply to its clients. A 3-in-1 tool combining forms, workflow and document generation that could sit on top of Office 365 was their ideal preference. FlowForma Process Automation’s no-code methodology and rapid prototyping capabilities only further rubber-stamped their decision.

Having a long history of delivering successful process automation projects, MicrotechDPS wanted to be able to combine its skills in this area by helping organizations leverage and build on top of any existing Microsoft Office 365 platform clients may have. FlowForma Process Automation was the perfect solution for them to deliver process automation to those who already have, or are considering moving to, SharePoint Online.

The new partnership emphasizes FlowForma’s commitment to empowering its global customer base, with the company excited to ramp-up operations in Australia and surrounding countries in the APAC region. From initial conversations, it became clear that both FlowForma and MicrotechDPS hold similar cultural and business values, meaning a partnership was the obvious and natural choice for both parties.

“We are thrilled to be working alongside FlowForma to provide our clients across Australia and the APAC region with a powerful process automation tool, to automate their business processes. From our initial conversations we could clearly see similarities in our customer base and the industries with which we serve, it was a unanimous decision,” said Joel Steers, General Manager, MicrotechDPS.

Olivia Bushe, CEO, FlowForma added: “It gives me great pleasure to announce MicrotechDPS as a FlowForma partner. We are truly excited of the potential opportunities this partnership can bring to construction, healthcare, finance and public organizations across the APAC region, helping them to digitize processes and prepare for a paperless and social distancing world.” 

Supporting Resources:

About FlowForma

FlowForma, the leading provider of Process Automation tools for Microsoft Office 365® has been revolutionizing the traditional BPM space with an innovative approach to developing award winning products that empower users to create and streamline processes smarter and faster, utilizing the familiar SharePoint platform, without any coding.

FlowForma is a Gold Microsoft Partner, with over 150,000 users across Europe, America, and Asia. The company is headquartered in Dublin with offices in London and Boston and is motivated by its values to innovate, evolve, and achieve with employees, customers and partners.

For further information or a 14-day free trial, visit www.flowforma.com

About MicrotechDPS

Established in 2004, MicrotechDPS provide a full suite of business technology services. Its holistic approach makes MicrotechDPS unique as a technology business partner by managing the lifecycle of a company’s IT & Print investments, from planning to procurement through to installation, training, and ongoing support. MicrotechDPS build long term relationships with its clients by learning and understanding what it is they do, and then match solutions to the activity that drives their business.

Photo – https://techent.tv/wp-content/uploads/2020/05/flowforma-microtechdps-join-forces-to-support-apac-region-with-process-automation-tools.jpg  
Logo – https://techent.tv/wp-content/uploads/2020/05/flowforma-microtechdps-join-forces-to-support-apac-region-with-process-automation-tools-1.jpg

VeChain and I-Dante Partnered to Create Blockchain Enabled Medical Data Management Platform for Healthcare Provider in Cyprus

SHANGHAI, May 18, 2020 /PRNewswire/ — With more than 4.6 million infections, 300 thousand deaths and counting caused by COVID-19, national governments, healthcare systems regardless of region and continent have been scrambling to respond to it, and the pandemic has highlighted the increasing demand for digital technologies to replace our old way of communication. VeChain is at the frontier of this digital transformation, solving the problems of the management of healthcare data by utilizing solutions powered by blockchain technology.

With the aim of enabling digital transformation in the healthcare sector, VeChain, together with I-Dante co-developed a blockchain-enabled medical data management platform named The E-NewHealthLife. Mediterranean Hospital of Cyprus, a hospital under the General Healthcare System of the Republic of Cyprus (GHS) is the first hospital to adopt this application.

Healthcare System Advancement
There have been efforts to modernize the technological infrastructure in the healthcare sector, but the problems include the administrative and technical difficulties of pooling data from different digital systems, the increasing cost, and the balance of health imperatives and privacy concerns, have greatly hampered the efforts. This dilemma has led to an urgent need for a low-cost yet highly-efficient digital solution.

With proven advantages in terms of secured data storage and efficient information sharing between multiple parties, blockchain technology has emerged as the best option in hand.

Blockchainized Actions In Response To The Challenges
There is a strong and urgent demand to deliver better and more efficient healthcare solutions that can achieve excellent patient-centric healthcare provision, secured data sharing, while complying with regulations on the use and sharing of patient data, which is solved in this case by the introduction of the E-NewHealthLife Web App in the Emergency Department of the hospital as the first phase of this project.

Powered by VeChain ToolChainTM, the Digital Healthcare Passport is an encrypted NFC Card that can be assigned to any patient of the hospital. The NFC Cards will allow the patients to identify themselves automatically at the Emergency Room registration desk, check their queue on mobile phone, manage their own medical records safely with the E-NewHealthLife Web App.

The blockchain powered application can serve both the hospitals internally and also end users. As The E-NewHealthLife fully complies with the GDPR (EU’s General Data Protection Regulation), the App enables the owner to have complete control over their profile and medical records. Data can only be shared to 3rd parties with the permission of the owner.

Bridging Trust In The Healthcare Sector
Blockchain is being posited as the next frontier in healthcare that will help solve the industry’s interoperability challenges. According to a report by BIS Research, the global healthcare market spending and investment on blockchain-based technologies is expected to hit $5.61 billion by 2025. The adoption of blockchain technology could save the healthcare industry up to $100$150 billion per year by 2025.

Based on concrete cases of multi party collaboration in various industries, VeChain has been accumulating experience in bridging trust and bringing in transparency into business while being compliant with local authorities and regulators. Given the huge potential of blockchain technology in the medical and healthcare sector, VeChain will continue to develop solutions for all stakeholders and pursue more opportunities in the near future.

About Mediterranean Hospital of Cyprus

The Mediterranean Hospital of Cyprus is a modern private health care institution, one of the largest in Cyprus, with a mission to provide to all the citizens and the visitors of the country safe and high quality medical services 24/7. The founder of the Mediterranean Hospital of Cyprus, Dr. Andreas Panayiotou has set as a goal the development and the establishment of a reliable infirmary, with flexible operational mechanisms, in order to gain the trust and recognition for the quality of its services from everybody. Mediterranean Hospital of Cyprus is the first private hospital that joined Cyprus’ General HealthCare System (GHS).

Website: www.medihospital.com.cy/en/

About I-DANTE LTD

Founded in December of 2019 by Etna Digital Growth (a consultancy- software house company in Italy) and CircleServus LTD (a consultancy company in Cyprus) in order to build digital healthcare solutions leveraging the power of the VeChainThor Blockchain.

Website: www.i-dante.com/

About VeChain

Launched in 2015, VeChain connects blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model, and IoT integration. VeChain is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco. Together with our strategic partners PwC and DNV GL, we have established cooperative relations with many leading enterprises in different industries, including Walmart China, BMW, BYD Auto, Haier, H&M, LVMH, D.I.G, ENN, AWS, PICC, ASI etc.

Website: www.vechain.com 

Photo – https://techent.tv/wp-content/uploads/2020/05/vechain-and-i-dante-partnered-to-create-blockchain-enabled-medical-data-management-platform-for-healthcare-provider-in-cyprus.jpg

Logo – https://techent.tv/wp-content/uploads/2020/05/vechain-and-i-dante-partnered-to-create-blockchain-enabled-medical-data-management-platform-for-healthcare-provider-in-cyprus-1.jpg

KT announces collaboration on ICT-based Epidemic Preparedness

SEOUL, South Korea, May 17, 2020 /PRNewswire/ — KT Corporation (KRX: 030200; NYSE: KT), South Korea’s largest telecommunications company, announced a three-year research study today funded by the Bill & Melinda Gates Foundation for ICT-based global epidemic response using artificial intelligence (AI) and Big Data.

Study of AI/Bigdata-based Epidemic Preparedness by KT and the Bill & Melinda Gates Foundation infographic
Study of AI/Bigdata-based Epidemic Preparedness by KT and the Bill & Melinda Gates Foundation infographic

The 10-million-dollar project stems from the recognition of South Korea’s advanced information and communication technology (ICT) as well as its proven ability to cope with the ongoing coronavirus pandemic.

The three-year research collaboration builds off discussions between the Gates Foundation and KT in 2019 and the research will be conducted in South Korea, which possesses a high mobile phone penetration rate and 5G infrastructure.

“With this contribution from the Gates Foundation, KT hopes to enhance our opportunity to lead the global effort toward outbreak prevention and response by taking advantage of AI and Big Data,” said Jeon Hongbeom, KT’s head of AI/DX Business Unit. “We also expect to contribute further to the Republic of Korea’s capabilities for epidemic response and preparedness, which has already been globally recognized.”

With Gates Foundation grant funding, KT will develop Big Data algorithms to improve early-diagnosis based on AI during an epidemic and prediction of viral infections spread using mobile data. Research expenses will be divided equally between the two organizations.

“The use of mobile technology and sensors paired with smart data analysis can help address some of the challenges countries face in timely and effective response to disease outbreaks,” said Andrew Trister, deputy director of digital health innovation at the Bill & Melinda Gates Foundation. “Knowing where a disease is moving and being able to predict spread can help save time and save lives. We’re pleased to be providing co-funding alongside Korea Telecom for this consortium of research partners. These will be valuable learnings for South Korea, and applicable to other geographies.”

The collaboration between KT and the Gates Foundation on improving global health has its origins at the data innovation working group by the World Economic Forum in 2018. Since then, the organizations have discussed collaboration on innovative epidemic response using ICT. In April 2019, KT introduced its Global Epidemic Prevention Platform (GEPP), which is to prevent the spread of infectious diseases using mobile data, at the ICT forum hosted by Research Investment for Global Health Technology Fund (RIGHT Fund), South Korea’s first funding agency dedicated to the Global Health R&D through the partnership between the Korean Government, Life Science companies, and the Gates Foundation, and the RIGHT Fund facilitated the discussions between the parties resulted in this three year partnership.

The project calls for KT to first develop a mobile app to automatically input symptoms typically associated with viral infections. An Internet of Things (IoT) body temperature sensor will be among the tools. Symptoms and body temperature will be analyzed with AI to create an algorithm that will calculate the probability of infection.

KT will also use mobile data to examine human mobility patterns and regions with epidemics to determine the direction of the infection spread. At the same time, it will analyze virus trends by region and develop forecasting models to predict seasonal outbreak for each region.

KT expects the research will contribute to global management of epidemics and pandemics. Technically, it will sound an alarm when an infectious disease appears to help prevent massive outbreaks and improve chances of treatment and survival through self-testing.

On one hand, KT forms a consortium with its domestic partners. Korea University Hospital will be tasked with analyzing pathogen genome sequencing; Korea Institute of Science and Technology Information with forecasting models of viral inflow and proliferation; Mobile Doctor with conducting app-based diagnostic data analysis; and MediBloc with developing a blockchain-based platform for sharing user data.

South Korea’s advanced ICT infrastructure has made decisive contributions to the tract-tracing of virus infection as well as social distancing through work from home, remote education and teleconferencing. Those who are infected are isolated at home and monitored through a smartphone app for “self-quarantine safety protection.”

In the wake of the 2015 outbreak of MERS (Middle East Respiratory Syndrome), KT developed its GEPP service in collaboration with the Korea Centers for Disease Control and Prevention and the Ministry of Science and ICT. The multifunction platform warns of epidemic outbreaks and offers relevant information to travelers while tracing their movement to help stop disease transmission.

The global health area, where KT is partnering, aims for better public health in developing countries through development and application of innovative solutions.

MEDIA CONTACTS

For inquiries, please contact our Global Media Relations Team at kt.gmrt@gmail.com

ABOUT KT CORPORATION (KRX: 030200; NYSE: KT)

KT Corp., Korea’s largest telecommunications service provider, reestablished in 1981 under the Telecommunications Business Act, is leading the era of innovations in the world’s most connected country. The company is leading the 4th industrial revolution with high speed wire/wireless network and new ICT technology. KT launched the world’s first nationwide commercial 5G network on April 3, 2019, after successfully showcasing the world’s first trial 5G services at the PyeongChang Winter Olympic Games in February 2018. This is another milestone in KT’s continuous efforts to deliver essential products and services as it aspires to be the number one ICT Company and People’s Company.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/kt-announces-collaboration-on-ict-based-epidemic-preparedness-301060000.html

Source: KT Corp.

Coc Coc Shares Its Contribution in Fighting Against COVID-19 Epidemic

HANOI, Vietnam, May 15, 2020 /PRNewswire/ — Vietnam has made efforts to implement measures of the COVID-19 prevention and achieved positive results. To contribute to this success, businesses, especially technology companies, have taken numerous practical actions. As a leading Vietnamese technology company, Coc Coc has made timely contributions to the fight against COVID-19 in Vietnam. 

Despite having a wide border with China, Vietnam is currently one of the very few countries that has controlled the COVID-19 epidemic effectively with prompt and drastic policies of social distancing. The country is worldwide known with many creative communication campaigns which government, companies & people join hands to make it go viral, such as “Ghen Co-Vy” song & dance, rice ATM, 0 dong supermarket.

COVID-19 Search Page on Coc Coc Browser with 250,000 queries daily

As the progress of the COVID-19 epidemic was getting more complicated in some countries, the amount of traffic in searching for COVID-19 related keywords increased dramatically. However, that facilitated the dissemination of false information, which mainly mentioned the number of COVID-19 positive patients, as well as the methods to prevent the disease. Before the situation of fake news quickly spread on the Internet, Coc Coc launched an updated information page of COVID-19 based on official sources on the Coc Coc search engine on February 10 to provide exact information for users to follow. Coc Coc is one of the first Vietnamese technology companies to develop a COVID-19 information page with such fast access speed and updated information. Users only need to type keywords related to Covid-19 such as “corona virus”, “coronavirus”, “nCoV”, “corona virus”, “2019-nCoV”, ” COVID-19″, “sars-cov-2” on Coc Coc browser (with 24M users) or accessing to the link, a complete news page of the COVID-19 pandemic developments will appear immediately. All necessary information of the disease such as symptoms, prevention methods, recommendations of the Ministry of Health are continually updated in the most concise and intuitive way. Users can look for information from both desktop and mobile, and easily share it with friends and relatives. After launching the news page, Coc Coc has recorded 250 thousand visits daily. And, Coc Coc has become the most popular COVID-19  news one in Vietnam and received a lot of requests from the overseas Vietnamese community to publish it in English version.

COVID-19 search page on Coc Coc receives 250,000 queries/day
COVID-19 search page on Coc Coc receives 250,000 queries/day

Communication to promote social distancing

Besides, Coc Coc also applies the chatbot of COVID-19 on their fanpage. When users directly send questions to Coc Coc’s fanpage, Coc Coc will have access to the information and give back the most accurate answers.

For users on Coc Coc’s mobile platform, Coc Coc immediately updates daily news about COVID-19, epidemic prevention information and government announcements via push notification.

After the social distancing instruction of the government, Coc Coc rapidly changed its Doodle so as to enthusiastically respond to the campaign “Staying at home is happy”. Especially, Coc Coc actively spread the message on the browser’s new tab page with more than 20 million views per day, in order to raise public awareness of the importance of keeping themselves and society safe.

Support package for COVID-19 affected clients

During a period of social distancing, Vietnam also encouraged businesses to offer assistance programs for people such as online payment, online work, and other online forms.With several suitable features for users working or learning online, Coc Coc tried their best to optimize those features to users for a better experience. In addition to the existing features, Coc Coc also released new features to meet entertainment demands such as Coc Coc Music, Coc Coc Game

At this time, Coc Coc is also implementing plans to provide advertising support packages so as to accompany businesses that are badly affected by the disease.

About Coc Coc:

Coc Coc is a Vietnamese browser, which was developed on Chromium open-source platform – a platform popularly used by other well-known web browsers such as Google Chrome and Opera. Overtaking IE, Firefox, Safari, Coc Coc has grown to be the second most popular web browser in Vietnam with nearly 18.4% market share of browsers by access and 5.8% that of search engines. In 2019, Coc Coc cooperated with Yandex, one of Europe’s largest internet companies, to launch the personalize newsfeed on Coc Coc Newtab that delivered remarkable growth in users and revenue.

Website: https://coccoc.com/

Photo – https://photos.prnasia.com/prnh/20200515/2805196-1?lang=0

Frost & Sullivan Assesses the Top 21 Global Risks that Threaten the Next Decade

Inability to mitigate global risks such as rise of infectious diseases like COVID-19 can adversely impact businesses, societies, and economies

SANTA CLARA, California, May 14, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Global Future Risks—Future-proofing Your Strategies, 2030, provides a compelling analysis that will help stakeholders understand the impact of future risks through the short, medium and long terms, and equip them to act on clear growth opportunities. The study presents over 80 growth opportunities arising from 21 risks, which will help policymakers, businesses and individuals take immediate tactical and strategic actions and draw plans to lower impact. Unpreparedness to address these challenges, which are looming across the globe, will adversely impact businesses, societies, economies, cultures, and personal lives.

Global Future Risks
Global Future Risks

For further information on this analysis, please visit: http://frost.ly/43o

“Risks are now increasingly interconnected, which, if amplified, can trigger a ripple effect across industries, regions, and diverse stakeholder groups. Therefore, mitigating them will involve measures to quantify relevant risks, estimate the probability of occurrence and the adoption of a cohesive, interdisciplinary, and multipronged approach,” said Murali Krishnan, Visionary Innovation Group Senior Industry Analyst at Frost & Sullivan.

Krishnan added: “With an estimated 200 billion connected devices by 2030, the risk of sophisticated cyberattacks will escalate. Therefore, companies should invest in future-casting tools that help identify the impact of such risks to their business, thereby detecting vulnerabilities and avoiding disruptions.”

“Over 40 million Americans are at risk of flooding from rivers, nearly 300,000 have lost their lives to the COVID pandemic, and close to $1 billion in costs will be borne annually by economies as they become victims to cyberattacks. The stakes are high, claiming both lives and resources. Businesses must look to invest in early warning systems that help future-proof them against the known and the unknown. Understanding risks and its levers can become a growth opportunity if used as a tool to create value,” noted Archana Vidyasekar, Visionary Innovation Group Research Director at Frost & Sullivan.

To tap into growth opportunities emerging from the short-, mid- and long-term risks, organizations can focus on the following areas:

Short-term risks

  • Privacy and disinformation risks: Organizations must adopt a “privacy-by-design” approach, which goes beyond accepted privacy standards and assumes global regulatory compliance.
  • Rise of infectious diseases: Advanced technologies such as next-generation sequencing (NGS) and CRISPR-based diagnostics will enable new approaches in the treatment of infectious diseases.
  • Water crisis: Innovation in agricultural practices such as vertical farming and optimized crop selection can play an important role in reducing the ongoing water crisis.

Mid-term risks

  • Urbanization: Urbanization stress will trigger the demand for smart solutions such as intelligent grid control and electrification, smart buildings, and smart storage solutions.
  • Climate change risks: Organizations will emphasize investments in buildings with net-zero energy consumption, and greenhouse gas emissions will increase minimally.

Long-term risks

  • Artificial intelligence (AI) as a threat: AI can be a strong reason for the polarization of jobs across the world, but investing in collaborative computational capabilities can help allocate an ideal division of tasks between humans and robots based on their distinct capabilities and deployment costs.
  • National identity crisis: Great business opportunities exist in providing digital authentication of eGovernment services such as digitization of birth, marriage, and death certificates, passports, and driving licenses.

Global Future Risks—Future-proofing Your Strategies, 2030 is the latest addition to Frost & Sullivan’s Visionary Innovation research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Global Future Risks—Future-proofing Your Strategies, 2030
K3FB

Contact:
Francesca Valente
P: +54 11 4777 5300
E: mailto:francesca.valente@frost.com
http://ww2.frost.com

Photo – https://techent.tv/wp-content/uploads/2020/05/frost-sullivan-assesses-the-top-21-global-risks-that-threaten-the-next-decade.jpg

Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan

Demand for telehealth will soar by 64.3% in the US in 2020 as the COVID-19 pandemic disrupts the practice of medicine and the delivery of healthcare

SANTA CLARA, California, May 14, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Telehealth—A Technology-Based Weapon in the War Against the Coronavirus, 2020, finds that the demand for telehealth technology is expected to rise dramatically as the COVID-19 pandemic continues to disrupt the practice of medicine and the delivery of healthcare worldwide. The telehealth market in the United States (US) is estimated to display staggering seven-fold growth by 2025, resulting in a five-year compound annual growth rate (CAGR) of 38.2%. In 2020, the telehealth market is likely to experience a tsunami of growth, resulting in a year-over-year increase of 64.3%.

Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan
Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan

For further information on this analysis, please visit: http://frost.ly/43e.

“The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider,” said Victor Camlek, Healthcare Principal Analyst at Frost & Sullivan. “However, all stakeholders need to remember that many people use the terms ‘telehealth’ or ‘telemedicine’ without understanding the ecosystem that is involved. This study will clarify the many components that are needed in order to implement telehealth.”

Camlek added: “Across the market segments, virtual visits and remote patient monitoring (RPM) will propel the overall market of telehealth, followed by mHealth and personal emergency response systems (PERS). Further, patients will benefit if data from RPM is fully available to virtual visit providers. This trend will demonstrate the benefit of integrated services. The trauma resulting from the COVID-19 crisis will lead to a clear growth opportunity for one-stop virtual visit and RPM solutions.”

The opportunity for telehealth products and services to become a standard of care is growing. The challenge facing these technology and healthcare providers will focus on their ability to scale-up to this unprecedented demand. Growth in the telehealth space will be sustained beyond the COVID-19 pandemic for the vendors who can deliver:

  • User-friendly sensors and remote diagnostic equipment that yield a high rate of successful patient outcomes following the telehealth experience.
  • Practical applications of artificial intelligence (AI), Interactive Virtual Assistants (IVAs), and robotics that expand the telehealth deployment model.
  • Deployment of big data analytics that can help researchers learn more about the way COVID-19 progresses among diverse patient populations.
  • Adherence to cybersecurity and privacy regulations that avoid data breaches following the use of telehealth services.
  • Measurable data that confirms the value of telehealth and influences regulatory agencies at the federal and state levels to extend all emergency waivers beyond the pandemic.

Telehealth—A Technology-Based Weapon in the War Against the Coronavirus, 2020 is the latest addition to Frost & Sullivan’s Transformational Health research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Telehealth—A Technology-Based Weapon in the War Against the Coronavirus, 2020
K488

Contact:
Mariana Fernandez
Corporate Communications
P: +1 (210) 348.1012
E: mariana.fernandez@frost.com 
https://www.frost.com

Photo – https://techent.tv/wp-content/uploads/2020/05/telehealth-to-experience-massive-growth-with-covid-19-pandemic-says-frost-sullivan.jpg

Bigo Live Announces ‘Global BIGOer One World Together’ Fundraising Campaign To Support WHO In Fight Against COVID-19

  • The “Global BIGOer One World Together” fundraising campaign brings together the global BIGO community to raise donations for the World Health Organization’s COVID-19 Solidarity Response Fund
  • Campaign highlights include the release of a music video featuring 100 broadcasters from over 20 countries, showcasing solidarity.
  • Viewers are invited to enjoy a 24-hour music live house featuring broadcasters from around the world starting 13 May 2020 at 9:00am PST to 14 May 2020, 9:00am PST as well as to donate to the Solidarity Response Fund on the Bigo Live app.

LOS ANGELES, May 12, 2020 /PRNewswire/ — Bigo Live, a global leading live streaming platform, today announced the ‘Global BIGOer One World Together‘ fundraising campaign in support of healthcare workers and vulnerable communities affected by COVID-19. The ‘Global BIGOer One World Together’ campaign brings together a cast of talented singers and musicians from around the world who will broadcast on Bigo Live app, with proceeds going to the World Health Organisation (WHO)’s Solidarity Response Fund.

Join BIGO LIVE broadcasters as they belt their way into your hearts and raise funds for WHO Solidarity Response Fund
Join BIGO LIVE broadcasters as they belt their way into your hearts and raise funds for WHO Solidarity Response Fund

Mike Ong, Vice President of BIGO Technology said “The ‘Global BIGOer One World Together’ fundraiser aims to rally and unite the community as one through the power of music. As a global platform that connects and brings people together, the campaign is aimed at fostering solidarity on a global scale for a very important cause. In collaboration with Bigo Live broadcasters, we hope to bring the community together to lend our support to frontline healthcare professionals and communities most in need during the COVID-19 pandemic.”

A music video showcasing solidarity was put together by over 100 broadcasters from over 20 countries performing a cover of the Michael Jackson hit “We Are The World”. It will be released on 12 May 2020 across all Bigo Live social media channels.

The main event is a 24-hour music livehouse on Bigo Live that will take place on 13 May 2020, starting at 9:00am PST. The music livehouse – a single ‘room’ on Bigo Live that will host the performances – will showcase broadcasters from around the world streaming right from their own homes or studios. Viewers will be able to engage and chat with the broadcasters as well as the community using the various features on the app. Viewers are encouraged to donate generously towards the fundraising efforts via the Bigo Live app.

Since the start of the outbreak, Bigo Live has launched a series of curated content by broadcasters around the world to bring comfort and happiness during these trying times. This included a #STAYATBIGO campaign which had sharing sessions with healthcare professionals, performances by local music DJs and workouts by fitness enthusiasts to help local communities stay fit and healthy at home. They have also been the first to bring cloud clubbing as a form of entertainment to communities in Southeast Asia, Australia and New Zealand.

“The fight against COVID-19 is a long and arduous one. As with previous campaigns over the past few months, we hope that the Global BIGOer One World Together campaign will help bring people together and show our solidarity towards frontline professionals, while also being able to spread some joy and cheer,” Mike added.

Viewers can expect to see popular broadcasters from the country like “RazB_B2K”, “Djer” and “HalleHallelujah” perform in-app between 5:30pm, PST to 7:00pm, PST on 13 May 2020.

To join ‘Global BIGOer One World Together’ live stream, search for the Bigo ID: “music” in the app.

Web users can also join the music live house via this link here: https://bigolive.onelink.me/sG8X/Livehouse

About Bigo Live

Bigo Live is one of the world’s fastest-growing livestreaming social communities where users broadcast in real-time to share life moments, showcase their talents and interact with people from around the world. Bigo Live has around 400 million users in over 150 countries and is currently the market leader in the livestreaming industry. Launched in March 2016, Bigo Live is owned by BIGO Technology which is based in Singapore.

Download the Bigo Live app here: https://bigolive.onelink.me/sG8X/bigoliveth

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bigo-live-announces-global-bigoer-one-world-together-fundraising-campaign-to-support-who-in-fight-against-covid-19-301057298.html

Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations

VISTA, California, May 12, 2020 /PRNewswire/ — Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 second scan time at 40x magnification, the Aperio GT 450 DX, registered as CE IVD and TGA, allows healthcare organizations to scale up digital pathology so they can meet ever-increasing demands without sacrificing quality.

Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations
Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations

The Aperio GT 450 DX System was rigorously tested by technicians and pathologists in Asia, including at Seoul National University Hospital (SNUH), a leading digital pathology hospital in South Korea, to determine the workflow impact.

“The Aperio GT 450 DX next generation imaging solution innovatively reduces the pre-scan process and scanner technician time, while maintaining sharp image quality and color for the pathologist. We expect that these workflow time savings will allow us to scale up our digital pathology operations instead of using the current conventional glass slide-based diagnosis,” said Prof. Kyoungbun Lee, Department of Pathology, Seoul National University Hospital, who led the beta testing of the Aperio GT 450 DX.

“We are excited about this innovative product as it delivers the benefit of improved throughputs, reduced turnaround time and high-quality images for our healthcare professionals,” said Colin White, Global Vice President, Advanced Staining and Imaging at Leica Biosystems.

For In Vitro Diagnostic Use. The clinical use claims described for the products in the information supplied have not been cleared or approved by the U.S. FDA or are not available in the US.

Aperio GT 450 at Leica Biosystems Virtual Digital Pathology Summit
On May 19th and 20th, 2020, thought leaders from around the globe will gather to showcase talks on the latest topics and advances in digital pathology whilst providing a collaborative and interactive experience in a virtual environment. Learn more about the Aperio GT450 DX during this virtual summit.

About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps.  Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.  Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.

Media Contact: Melissa Crothers, Global Marketing Communications Manager
Phone: 760-539-1193
Email: LBS-GlobalMarketing@leicabiosystems.com 

Photo – https://techent.tv/wp-content/uploads/2020/05/leica-biosystems-launches-aperio-gt-450-dx-in-asia-enabling-high-volume-clinical-labs-to-scale-up-digital-pathology-operations.jpg

111 to Launch First Online Diabetes Patient Management Platform with Lilly China

SHANGHAI, May 8, 2020 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (Nasdaq: YI), a leading integrated online and offline healthcare platform in China, today announced that it is launching a new diabetes patient management platform in cooperation with Lilly China.

The two companies will work together to build a comprehensive diabetes patient management platform that includes services such as disease management, disease education and patient support programs to enrich patients’ knowledge of chronic disease management and to better help diabetic patients to self-manage from home. The platform will seek to harness the power of internet hospital technologies, big data and artificial intelligence technologies to provide diabetic patients with a comprehensive digital health management solution.

111 has accumulated extensive experience in operations management in the area of chronic disease, especially in diabetes, laying a solid foundation for the development of the diabetes management platform. With the transformative power of technology, the platform will seek to provide patients with a one-stop solution for “physician consultation + medication” services, allowing patients to consult with qualified physicians online, and receive personalized healthcare management services, online refill service, and medication delivery services.

As the first multinational pharmaceutical company to join the platform, Lilly China will leverage its expertise in the field of diabetes management and will also offer a variety of patient management and support programs, including “Lilly Connected Care Program” and Patient Benefit Program, to eligible diabetes patients, with the aim of providing personalized disease education and health management services. In addition, with its deep experience in the diabetes field, Lilly China will help to develop a directory of disease education resources to help patients understand risk factors, signs and symptoms, and treatment options. 

Commenting on Lilly’s collaboration with 111, President and General Manager of Lilly China, Mr. Julio Gay-Ger, said, “The internet + healthcare model has increasingly gained recognition from the Chinese government, and Lilly China is actively exploring innovative business models in collaboration with a number of third-party platforms, including internet hospitals. Joining 111’s diabetes patient platform is an opportunity for Lilly China to conduct disease management and education through online hospitals, and also improve access to Lilly China’s various patient support and benefit programs for diabetic patients.”

“China has over 100 million diabetic patients, and it is crucial to help this large group of patients to manage their health effectively,” said Dr. Yu Gang, Co-Founder and Executive Chairman of 111. “As a technology enabler of the pharmaceutical health ecosystem, 111 looks forward to working with Lilly China to leverage resources and core competence in each of our respective fields, and explore an efficient management model of diabetes. This collaboration aims to deliver better care and medical outcomes for patients with chronic diseases by developing an integrated digital health management platform. Our ambition is to leverage on technology to overcome the constraints of time and location to provide greater convenience for both patients and physicians,” Dr. Yu Gang noted. “Through our platform, we hope to provide patients with better access to information on diet, exercise, and medication specifically tailored to their individual needs, as well as a personalized management and treatment program that could help improve their own health. A step closer to the goals of Healthy China 2030.”

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s new retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit http://ir.111.com.cn/.

For more information, please contact:

111, Inc.
Media Relations 
Email: press@111.com.cn 
Phone: +86-021-2053 6666 (China)

111, Inc.
Investor Relations
Email: ir@111.com.cn

GCM Strategic Communications
IR Counsel
Email: 111.ir@gcm.international

Cision View original content:http://www.prnewswire.com/news-releases/111-to-launch-first-online-diabetes-patient-management-platform-with-lilly-china-301055612.html

Source: 111, Inc.